Company Plans U.S. Future for Cannabis Drug (Reuters)


Reuters - Britain's GW Pharmaceuticals said Monday
it was accelerating plans to introduce its cannabis-based
medicines into the United States as U.S. founder investors
increased their stake in the business.

Read more...